The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.

Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.

wallstreetcnNov 17 07:00 ET

Eli Lilly, Novo Nordisk Shares Slide as Trump Picks RFK Jr. for HHS Post

MarketWatchNov 15 14:25 ET

Morgan Stanley Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $118

Moomoo NewsNov 15 08:31 ET · Ratings

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference

GlobeNewswireNov 15 08:30 ET

Jefferies Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $79

Moomoo NewsNov 14 08:35 ET · Ratings

Structure Therapeutics Reports Strong Q3 2024 Results

TipRanksNov 13 23:35 ET